Sensitivity to nonsteroidal anti-inflammatory drugs

Annals of Allergy, Asthma and Immunology

Volumn 89, Issue 6, 2002, Pages 542-550

  Namazy, Jennifer Altamura ^a   Simon, Ronald A ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; LYSINE ACETYLSALICYLATE; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; ZILEUTON;

ALLERGIC ASTHMA; ALLERGIC PNEUMONITIS; ALLERGIC RHINITIS; ALLERGIC URTICARIA; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASEPTIC MENINGITIS; CLINICAL FEATURE; CLINICAL TRIAL; DESENSITIZATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; HUMAN; INFLAMMATORY CELL; NOSE POLYP; PATHOGENESIS; PATIENT EDUCATION; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT DISEASE; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0036977360     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62099-6     Document Type: Review

References (61)

1. Stevenson D, Simon RA, Zuraw B. Sensitivity to aspirin and non-steroidal anti-inflammatory drugs. In: Middleton E, Jr, Ellis EF, Yunginger JW, et al, editors. Allergy: Principles and Practice. St. Louis: Mosby, 2002:(in press).
2. Stevenson D, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclo-oxygenase enzymes. Ann Allergy 2001;87:177-180.
3. Giraldo B, Blumenthal MN, Spink WW. Aspirin intolerance and asthma: a clinical and immunological study. Ann Intern Med 1969;71:479-496.
4. McDonald JR, Mathison DA, Stevenson DD. Aspirin intolerance in asthma, detection by oral challenge. J Allergy Clin Immunol 1972;50:198-207.
5. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000;16: 432-436.
6. Stevenson D. Adverse reactions to nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am 1998;18: 773-798.
7. Pleskow WW, Stevenson DD, Mathison DA, et al. Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin. J Allergy Clin Immunol 1983;71:574-579.
8. Pauls JD, Simon RA, Daffern PJ, Stevenson DD. Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol 2000;85:40-45.
9. Stevenson D, Simon RA, Mathison DA, Christiansen SC. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol 2000;85:477-482.
10. Stevenson DD. Oral challenges to detect aspirin and sulfite sensitivity in asthma. N Engl Reg Allergy Proc 1988;9: 135-142.
11. Szczeklik A, Serwonska M. Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine. Thorax 1979;34: 654-657.
12. Stevenson DD, Simon RA, Mathison DA. Cromolyn pretreatment delays onset of aspirin (ASA) induced asthmatic reactions. J Allergy Clin Immunol 1984;73:162.
13. Pleskow WW, Stevenson DD, Mathison DA. Aspirin sensitivity rhinosinusitis/asthma: spectrum of adverse reactions. J Allergy Clin Immunol 1983;71:574.
14. Lumry WR, Curd JG, Zeiger RS, et al. Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration. J Allergy Clin Immunol 1983;71:580-587.
15. Bosso JV, Simon RA. Urticaria, angioedema and anaphylaxis provoked by food additives. In: Metcalfe DD, Sampson HA, Simon RA, editors. Food Allergy: Adverse Reactions to Foods and Food Additives. Boston: Blackwell Scientific Publications, 1991:288-300.
16. Czerniawska-Mysik G, Szczeklik A. Idiosyncrasy to pyrazolone drugs. Allergy 1981;36:381-386.
17. Quiralte J, Blanco C, Castillo R et al. Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies. Ann Allergy Asthma Immunol 1997;78: 293-296.
18. Stevenson D. Anaphylactic(toid) reactions to aspirin and NSAIDs. North Am Clin Allergy Immunol 2001;21:11-21.
19. Stevenson D. Adverse reactions to nonsteroidal anti-inflammatory drugs. North Am Clin Allergy Immunol 1998;18: 773-798.
20. Bianco S, Robuschi M, Petrigini G. Aspirin-induced tolerance in aspirin-asthma detected by a new challenge test. IRCS J Med Sci 1977;5:129-136.
21. Dahlen B, Zetterstrom O. Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics. Eur Respir J 1990;3:527-534.
22. Widal MF, Abrami P, Lermeyez J. Anaphylaxie et idiosyncrasie. Presse Med 1922;30:189.
23. Stevenson DD, Simon RA, Mathison DA. Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 1980;66:82-85.
24. Pleskow WW, Stevenson DD, Mathison DA, et al. Aspirin desensitization in aspirin-sensitive asthmatic patients: Clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol 1982;69:11-19.
25. Stevenson DD, Hankammer MA, Mathison DA, et al. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996;98:751-758.
26. Szczeklik A, Gryglewski RJ, Czemiawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977;60: 276-284.
27. Delaney JC. The diagnosis of aspirin idiosyncrasy by analgesic challenge. Clin Allergy 1976;6:177-184.
28. Settipane RA, Stevenson DD. Cross-sensitivity with acetaminophen in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol 1989;84:26-33.
29. Stevenson DD. Cross-reactivity between aspirin and other drugs/dietary chemicals: a critical review. In: Pichler WJ, Stadler MM, Dahinden CA, editors. Progress in Allergy and Clinical Immunology. Lewiston, NY: Hogrefe and Huber, 1989: 462-473.
30. Feigenbaum BA, Stevenson DD, Simon RA. Hydrocortisone sodium succinate does not cross-react with aspirin in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol 1995; 96:545-548.
31. Stevenson DD, Simon R. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108:47-51.
32. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971;231:232-235.
33. Moneret-Vautrin DA, Hsieh V, Wayoff M, et al. Nonallergic rhinitis with eosinophilia syndrome a precursor of the triad: nasal polyposis, intrinsic asthma, and intolerance to aspirin. Ann Allergy 1990;64:513-518.
34. Sladek K, Dworski R, Soja J, et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994;149: 940-946.
35. Yamashita T, Tsuji H, Maeda N, et al. Etiology of nasal polyps associated with aspirin-sensitive asthma. Rhinol Suppl 1989;8: 15-24.
36. Samuelsson B, Hammarstrom S, Murphy RC, Borgeat A. Leukotrienes and slow reacting substance of anaphylaxis (SRS-A). Allergy 1980;35:375-381.
37. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991; 143:1025-1029.
38. 4 in bronchial asthma. Eur Respir J 1992;5:693-699.
39. Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 1990;3:588-593.
40. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999;104:5-13.
41. Juergens UR, Christiansen SC, Stevenson DD, Zuraw BL. Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge. J Allergy Clin Immunol 1992;90:636-645.
42. 4 in subjects with aspirin-induced asthma. Am Rev Respir Dis 1989;140:148-153.
43. 4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996; 153:572-575.
44. Ferreri NR, Howland WC, Stevenson DD, Spiegelberg HL. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reactions to aspirin. Am Rev Respir Dis 1988;137:847-854.
45. 4 production after aspirin desensitization. J Allergy Clin Immunol 1995;96:148-156.
46. Bosso JV, Schwartz LB, Stevenson DD. Tryptase and histamine release during aspirin-induced respiratory reactions. J Allergy Clin Immunol 1991;88:830-837.
47. Mathison DA, Lumry WR, Stevenson DD, et al. Aspirin in chronic urticaria and/or angioedema: studies of sensitivity and desensitization. J Allergy Clin Immunol 1982;69:135.
48. Moore-Robinson M, Warren RP. Effect of salicylates in urticaria. BMJ 1967;4:262.
49. Stevenson DD, Simon RA. Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In: Middleton E Jr, Reed CE, Ellis EF, et al, editors. Allergy Principles and Practice. St. Louis: CV Mosby Co, 1993: 1747-1765.
50. Kemp SF, Lockey RF, Wolf BL, Lieberman P. Anaphylaxis. A review of 266 cases. Arch Intern Med 1995;155:1749-1754.
51. Levy M, Fink J. Anaphylaxis to celecoxib. Ann Allergy 2001; 87:72-73.
52. Greenberg GN. Recurrent sulindac-induced aseptic meningitis in a patient tolerant to other nonsteroidal anti-inflammatory drugs. South Med J 1988;81:1463-1464.
53. Marinac JS. Drug and chemical-induced aseptic meningitis: a review of the literature. Ann Pharmacother 1992;26:813-821.
54. Weber JC, Eissigman WK. Pulmonary alveolitis and NSAIDs- fact or fiction? Br J Rheumatol 1986;25:5-6.
55. Nader DA, Schillaci RF. Pulmonary infiltrates with eosinophilia due to naproxene. Chest 1983;83:280-282.
56. Buscaglia AJ, Cowden FE. Pulmonary infiltrates associated with naproxene. J Am Med Assoc 1984;1:65-66.
57. Goodwin SD, Glenny RW. Nonsteroidal anti-inflammatory drug-associated pulmonary infiltrates with eosinophilia. Review of the literature and Food and Drug Administration Adverse Drug Reaction reports. Arch Intern Med 1992;152:1521-1524.
58. Londino AV, Wolf GL, Calabro JJ. Naproxen and pneumonitis. J Am Med Assoc 1984;252:1853-1854.
59. Settipane RA, Shrank PJ, Simon RA, et al. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol 1995;96:480-485.
60. Dahlen B, Nizankowska E, Szczeklik A. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 1998; 157:1187-1194.
61. Kuna P, Malmstrom K, Dahlen SE, et al. Montelukast (MK- 0476) a cysLT1 receptor antagonist improves asthma control in aspirin-intolerant asthmatic patients. Am J Respir Crit Care Med 1997;155:A975.